Mohammad Hirmand
CIK 1654482 · EVP and Chief Medical Officer · last filed 2025-06-16
Mohammad Hirmand is an EVP and Chief Medical Officer who has filed 16 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for WHWK, was dated Jun 16, 2025. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
16
-$1.38M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Director | — | $4.16 | — | $0 | 1 | 2025-06-16 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | Director | — | $2.05 | — | $0 | 2 | 2024-06-14 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | EVP and Chief Medical Officer | 0 | $76.01 | $0 | -$1.26M | 5 | 2022-08-17 |
| MEDIVATION, INC. (MDVN) Delisted | Interim Chief Medical Officer | 45,583 | — | — | -$119.1K | 7 | 2016-09-19 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-16 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2024-06-14 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-29 | Whitehawk Therapeutics, Inc. (AADI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-17 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Disp (D) | −41,284 | -$3.14M | EDGAR |
| 2022-02-11 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Mixed | +33,314 | -$24.3K | EDGAR |
| 2021-02-10 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | +6,483 | $0 | EDGAR |
| 2021-01-05 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Mixed | −300 | -$693.1K | EDGAR |
| 2019-12-03 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-09-30 | — | Mixed | −57,752 | $0 | |
| 2016-09-19 | MEDIVATION, INC. (MDVN) Delisted | Exer (M) | +17,560 | $78.5K | EDGAR |